A critical breakthrough in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This essential malignant suppressor protein is frequently disabled in several types of tumors, causing https://sociallawy.com/story12573661/mini-antibodies-revive-tumor-suppressor-p53-the-new-hope-for-tumor-treatment